The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum
about
Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growthPerfluorinated chemicals and fetal growth: a study within the Danish National Birth CohortCord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birthA critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humansTranslating biomonitoring data into risk management and policy implementation options for a European Network on Human Biomonitoring.The use of biomonitoring data in exposure and human health risk assessmentsHuman biological monitoring of suspected endocrine-disrupting compoundsThe use of biomonitoring data in exposure and human health risk assessment: benzene case studyFactors Associated with Maternal Serum Levels of Perfluoroalkyl Substances and Organochlorines: A Descriptive Study of Parous Women in Norway and SwedenPolybrominated diphenyl ethers: a case study for using biomonitoring data to address risk assessment questionsAn interlaboratory study of perfluorinated alkyl compound levels in human plasma.The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomesHalf-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workersPregnancy serum concentrations of perfluorinated alkyl substances and offspring behaviour and motor development at age 5-9 years--a prospective studyPerfluoroalkyl Acid Concentrations in Blood Samples Subjected to Transportation and Processing Delay.Perfluoroalkyl acids and time to pregnancy revisited: An update from the Danish National Birth Cohort.Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APCmin mouse model of spontaneous familial adenomatous polyposis.Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population.Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water.Perfluoroalkyl Acids in Maternal Serum and Indices of Fetal Growth: The Aarhus Birth Cohort.Specific accumulation of lipid droplets in hepatocyte nuclei of PFOA-exposed BALB/c mice.Perfluorooctanesulfonate (PFOS) perturbs male rat Sertoli cell blood-testis barrier function by affecting F-actin organization via p-FAK-Tyr(407): an in vitro study.Breastfeeding: a potential excretion route for mothers and implications for infant exposure to perfluoroalkyl acidsStructure-activity relationships for perfluoroalkane-induced in vitro interference with rat liver mitochondrial respiration.Lactation history, serum concentrations of persistent organic pollutants, and maternal risk of diabetes.High Levels of Perfluorooctane Sulfonate in Children at the Onset of DiabetesAssociation of perfluorinated chemical exposure in utero with maternal and infant thyroid hormone levels in the Sapporo cohort of Hokkaido Study on the Environment and Children's Health.Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women.Rescue of PFOS-induced human Sertoli cell injury by overexpressing a p-FAK-Y407E phosphomimetic mutant.Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.Assessment of a mouse xenograft model of primary colorectal cancer with special reference to perfluorooctane sulfonatePerfluorooctanoic Acid (PFOA) Exposure in Early Life Increases Risk of Childhood Adiposity: A Meta-Analysis of Prospective Cohort Studies
P2860
Q24647791-9C3C846E-14E0-4B49-9BEB-E9F367F91036Q24680484-22ECC168-08A5-4709-9FA6-31F23278D736Q24680500-DF4CB6FC-72D3-4585-9E4F-4B8E25AA8B44Q28072372-62C07AC0-8110-4FFF-88F6-4BA85429681DQ28384597-C9F0EFE9-DECB-446E-9127-26F672006873Q28392450-0EA47E82-6AB8-445F-A691-3E87AB5858F4Q28394887-E233CE7C-85AD-449F-8CF2-3CD7706CABFDQ28395056-C95DB789-A2E5-497A-971B-3A26AD88BAD9Q28553267-47169F47-3EB3-40AC-9508-9C668D042F94Q33263713-9F985927-1388-4988-B239-4CE73C2B9FC1Q33607343-A1C29848-7787-4920-8907-B9A69587C584Q34275302-A3ED63EC-63D3-4624-B7EE-AC1A8480FD86Q34680365-784220A7-1A01-4C66-9AFB-B131439BFA2BQ34981222-D78C0F69-F49F-4A09-B6DC-A73DB9D92B88Q35769251-38D6BD08-B50E-432B-AB58-C24BAECD8EB0Q35825900-4290C4F0-F5BA-4768-A46A-6EEA63CAC056Q36215197-DA247104-9F44-408A-9738-60AE59126812Q36618735-9EE5A5CC-4409-4537-8C10-08E7A1295B24Q36633077-55F6FB18-BA78-4C00-8EC7-D9634EEF45A6Q36968190-D00ACAC4-029C-4AD8-8E11-2AF874A0FCE3Q37005160-4465D820-6C9F-44C2-AAC8-3CEE43EB39D3Q37405137-963E4117-59A7-46FF-9A8C-B643C7852591Q37559503-44611F5E-FADF-4411-82DD-128410235B6CQ37604541-2C1A5FC0-B503-4945-8B97-BAACC6BB5263Q40686061-472A7981-B5F7-4A48-B972-658EC3130B3BQ40813892-40CC8ADA-59A0-4BED-B11C-B176BF45A41CQ42321904-3CFA344C-97D3-4D86-A25A-55AC4EA2BBE3Q47106665-87F60565-1A86-4559-BE98-1511202C43D2Q47109568-9C39B4D9-7122-4171-BD7B-63F0EA8EC1ABQ49644181-7CF38C78-1B6F-4889-8ED0-D559CD9430A4Q58617824-595CBAA4-4A71-491A-BC8E-7DB8BED904D0Q58702616-A0AFCAF0-02CB-42DA-96FF-036FB8365EB0
P2860
The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The applicability of biomonito ...... mental public health continuum
@ast
The applicability of biomonito ...... mental public health continuum
@en
type
label
The applicability of biomonito ...... mental public health continuum
@ast
The applicability of biomonito ...... mental public health continuum
@en
prefLabel
The applicability of biomonito ...... mental public health continuum
@ast
The applicability of biomonito ...... mental public health continuum
@en
P2093
P2860
P921
P356
P1476
The applicability of biomonito ...... mental public health continuum
@en
P2093
Andrea Pfahles-Hutchens
Geary W Olsen
John L Butenhoff
P2860
P304
P356
10.1289/EHP.9060
P577
2006-11-01T00:00:00Z